Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shelly T Karuna

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Annual Review of Medicine|January 28, 2020
Broadly Neutralizing Antibodies for HIV PreventionShelly T Karuna, Lawrence Corey
Vaccine|July 18, 2013
Behavioral risk assessment in HIV Vaccine Trials Network (HVTN) clinical trials: a qualitative study exploring HVTN staff perspectivesMichele Peake Andrasik, Shelly T Karuna, Michelle Nebergall, et al.
Plos One|October 1, 2014
The inner foreskin of healthy males at risk of HIV infection harbors epithelial CD4+ CCR5+ cells and has features of an inflamed epidermal barrierMaria P Lemos, Javier R Lama, Shelly T Karuna, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 19, 2016
Engaging Transgender People in NIH-Funded HIV/AIDS Clinical Trials ResearchRona L Siskind, Michele Andrasik, Shelly T Karuna, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 26, 2013
Intentions to use preexposure prophylaxis among current phase 2B preventive HIV-1 vaccine efficacy trial participantsJonathan D Fuchs, Magdalena E Sobieszczyk, Tamra Madenwald, et al.
Vaccine|December 3, 2014
Use of placebos in Phase 1 preventive HIV vaccine clinical trialsYunda Huang, Shelly T Karuna, Holly Janes, et al.
Plos One|August 19, 2016
Transient Peripheral Immune Activation follows Elective Sigmoidoscopy or Circumcision in a Cohort Study of MSM at Risk of HIV InfectionJavier R Lama, Shelly T Karuna, Shannon P Grant, et al.
Open Forum Infectious Diseases|July 22, 2024
Oral Preexposure Prophylaxis Uptake and Discontinuation in the HIV Vaccine Trials Network 704/HIV Prevention Trials Network 085 Study: Implications for Biomedical Human Immunodeficiency Virus Prevention TrialsValeria D Cantos, Moni Neradilek, Yunda Huang, et al.
The Journal of Clinical Investigation|October 2, 2014
HIV-specific humoral responses benefit from stronger prime in phase Ib clinical trialPierre-Alexandre Bart, Yunda Huang, Shelly T Karuna, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 19, 2025
Brief Report: Associations Between Gender and Solicited Adverse Events After Passive Infusion of VRC01 or Placebo in HVTN 704/HPTN 085Deborah A Theodore, Moni Neradilek, Kevin Gillespie, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Annual Review of Medicine|January 28, 2020
Broadly Neutralizing Antibodies for HIV PreventionShelly T Karuna, Lawrence Corey
Vaccine|July 18, 2013
Behavioral risk assessment in HIV Vaccine Trials Network (HVTN) clinical trials: a qualitative study exploring HVTN staff perspectivesMichele Peake Andrasik, Shelly T Karuna, Michelle Nebergall, et al.
Plos One|October 1, 2014
The inner foreskin of healthy males at risk of HIV infection harbors epithelial CD4+ CCR5+ cells and has features of an inflamed epidermal barrierMaria P Lemos, Javier R Lama, Shelly T Karuna, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 19, 2016
Engaging Transgender People in NIH-Funded HIV/AIDS Clinical Trials ResearchRona L Siskind, Michele Andrasik, Shelly T Karuna, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 26, 2013
Intentions to use preexposure prophylaxis among current phase 2B preventive HIV-1 vaccine efficacy trial participantsJonathan D Fuchs, Magdalena E Sobieszczyk, Tamra Madenwald, et al.
Vaccine|December 3, 2014
Use of placebos in Phase 1 preventive HIV vaccine clinical trialsYunda Huang, Shelly T Karuna, Holly Janes, et al.
Plos One|August 19, 2016
Transient Peripheral Immune Activation follows Elective Sigmoidoscopy or Circumcision in a Cohort Study of MSM at Risk of HIV InfectionJavier R Lama, Shelly T Karuna, Shannon P Grant, et al.
Open Forum Infectious Diseases|July 22, 2024
Oral Preexposure Prophylaxis Uptake and Discontinuation in the HIV Vaccine Trials Network 704/HIV Prevention Trials Network 085 Study: Implications for Biomedical Human Immunodeficiency Virus Prevention TrialsValeria D Cantos, Moni Neradilek, Yunda Huang, et al.
The Journal of Clinical Investigation|October 2, 2014
HIV-specific humoral responses benefit from stronger prime in phase Ib clinical trialPierre-Alexandre Bart, Yunda Huang, Shelly T Karuna, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 19, 2025
Brief Report: Associations Between Gender and Solicited Adverse Events After Passive Infusion of VRC01 or Placebo in HVTN 704/HPTN 085Deborah A Theodore, Moni Neradilek, Kevin Gillespie, et al.
Pageof 3